Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

colon colorectal cancer CTC

Lack of Medicare coverage for CT colonography dragging down screenings, with Black patients hit harder

The number of CTC exams plummets by an average of 6.9% per year of age after 65, researchers reported in JACR.

Thumbnail

Siemens Healthineers clears key hurdle in $16.4B acquisition of cancer tech company Varian

Shareholders for the Palo Alto, California-based firm recently gave their "overwhelming" approval to the deal. 

quality excellence star stethoscope

The 5 most common mistakes to avoid in radiology quality improvement projects

Hubris is the fundamental failure of most such endeavors, Stanford imaging experts wrote in JACR

Thumbnail

Outpatient care volumes bouncing back, albeit unevenly

Weekly visits to some specialty practices have bounced back from the COVID swoon and then some. For many of these winners, in-person care is coming back to life right alongside telehealth.

Thumbnail

Tower Radiology forms partnership in Tampa; practice acquired in Washington, plus more company news

Also, Collaborative Imaging adds another practice to its growing roster of independent radiologists. 

New CEO at Intelerad, top radiologist retires, Carilion’s chief of radiology, and more leadership news

Also, one of Philadelphia's noted ultrasound experts passes away and ACR's chief executive wins big.

Thumbnail

Radiology department uses a systems-based approach to reduce unscheduled imaging orders by 49%

Harvard experts recently detailed their System for Coordinating Orders for Radiology Exams, or SCORE, in JACR

Brit study: Money-motivated parties weighed in heavily on FDA’s medical AI regulation

Of 125 public comments submitted to the FDA on how best to regulate AI software as a medical device, nearly two-thirds came from parties with financial ties to industry, according to a study running in BMJ Open.